University of Kentucky
Lexington, KY
Dr. Jill Kolesar received a Doctor of Pharmacy and completed a specialty practice residency in oncology/hematology and a 2-year fellowship in molecular oncology pharmacotherapy at the University of Texas Health Science Center in San Antonio, Texas. Dr. Kolesar is currently a Professor of Pharmacy at the University of Kentucky College of Pharmacy and the Director of the Early Phase Clinical Trials Center at the Markey Cancer Center. Her research focuses on the clinical pharmacology of anticancer agents. She has authored more than 200 abstracts, research articles, and book chapters, and as a principal investigator, she has received more than $750,000 in research funding from the NCI, ACS and other sources. In addition, she holds 2 US patents for novel assay methodologies for gene expression and mutation analysis. She has received several research awards from local, national and international pharmacy organizations and a Merit Award from the American Society of Clinical Oncology. She received the Innovations in Teaching Award from the American Association of Colleges of Pharmacy in 2001. Dr. Kolesar serves on the editorial board of the journal Cancer Chemotherapy and Pharmacology and the textbook Pharmacotherapy: Principles and Practice. She is the Co-Chair of the Lung Biology subcommittee of ECOG-ACRIN.